NASDAQ:TRHC Tabula Rasa HealthCare (TRHC) Stock Forecast, Price & News $6.30 +0.24 (+3.96%) (As of 02:34 PM ET) Add Compare Share Share Today's Range$6.04▼$6.3550-Day Range$5.11▼$6.0652-Week Range$2.33▼$6.69Volume138,276 shsAverage Volume117,250 shsMarket Capitalization$169.16 millionP/E RatioN/ADividend YieldN/APrice Target$6.63 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Tabula Rasa HealthCare MarketRank™ ForecastAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside5.2% Upside$6.63 Price TargetShort InterestBearish5.79% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthDecreasingFrom ($0.91) to ($0.99) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.07 out of 5 starsMedical Sector958th out of 981 stocksBusiness Services, Not Elsewhere Classified Industry90th out of 90 stocks 1.3 Analyst's Opinion Consensus RatingTabula Rasa HealthCare has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $6.63, Tabula Rasa HealthCare has a forecasted upside of 5.2% from its current price of $6.30.Amount of Analyst CoverageTabula Rasa HealthCare has only been the subject of 2 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted5.79% of the float of Tabula Rasa HealthCare has been sold short.Short Interest Ratio / Days to CoverTabula Rasa HealthCare has a short interest ratio ("days to cover") of 11.8, which indicates bearish sentiment.Change versus previous monthShort interest in Tabula Rasa HealthCare has recently decreased by 13.75%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldTabula Rasa HealthCare does not currently pay a dividend.Dividend GrowthTabula Rasa HealthCare does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TRHC. Previous Next 0.6 News and Social Media Coverage MarketBeat Follows8 people have added Tabula Rasa HealthCare to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Tabula Rasa HealthCare insiders have not sold or bought any company stock.Percentage Held by Insiders30.30% of the stock of Tabula Rasa HealthCare is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions60.90% of the stock of Tabula Rasa HealthCare is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Tabula Rasa HealthCare are expected to decrease in the coming year, from ($0.91) to ($0.99) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Tabula Rasa HealthCare is -1.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Tabula Rasa HealthCare is -1.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here About Tabula Rasa HealthCare (NASDAQ:TRHC) StockTabula Rasa Healthcare, Inc. is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. It operates through the following segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides services, PACE, which is a center for Medicare & Medicaid services, or CMS, sponsored program providing medical and social services. Its brands include CareKinesis, Capstone Risk Adjustment Services, PACElogic, TruChart, PeakTPA, PersonifilRx, and Pharmastar. The MedWise HealthCare segment provides Medication Therapy Management, or MTM, software and services for Medicare, Medicaid, and commercial health plans, and also provides a cloud-based patient engagement software and services. It offers cloud-based software and clinical pharmacist services through its brands, including MedWise, SinfoníaRx, RxCompanion, PrescribeWellness, and DoseMeRx. The company was founded by Calvin H. Knowlton, Orsula V. Knowlton, and Michael Greenhalgh in April 2009 and is headquartered in Moorestown, NJ.Read More Receive TRHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tabula Rasa HealthCare and its competitors with MarketBeat's FREE daily newsletter. Email Address TRHC Stock News HeadlinesMay 30, 2023 | americanbankingnews.comTabula Rasa HealthCare, Inc. (NASDAQ:TRHC) Short Interest UpdateMay 27, 2023 | americanbankingnews.comHead to Head Comparison: Steel Connect (NASDAQ:STCN) & Tabula Rasa HealthCare (NASDAQ:TRHC)June 8, 2023 | Edge On The Street (Ad)New "Mined in America" Lithium Opportunities?The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.May 19, 2023 | americanbankingnews.comTabula Rasa HealthCare (NASDAQ:TRHC) Receives New Coverage from Analysts at StockNews.comMay 17, 2023 | finance.yahoo.comMountain Empire PACE Signs with TRHC for Expanded ServicesMay 12, 2023 | msn.comSVB Leerink Upgrades Tabula Rasa HealthCare (TRHC)May 11, 2023 | americanbankingnews.comTabula Rasa HealthCare (NASDAQ:TRHC) Upgraded by SVB Leerink to OutperformMay 11, 2023 | americanbankingnews.comTabula Rasa HealthCare (NASDAQ:TRHC) Stock Rating Upgraded by SVB LeerinkJune 8, 2023 | Edge On The Street (Ad)New "Mined in America" Lithium Opportunities?The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.May 10, 2023 | finance.yahoo.comQ1 2023 Tabula Rasa HealthCare Inc Earnings CallMay 10, 2023 | americanbankingnews.comTabula Rasa HealthCare (NASDAQ:TRHC) Upgraded to Outperform at SVB SecuritiesMay 10, 2023 | marketwatch.com8-K: Tabula Rasa HealthCare, Inc.May 9, 2023 | finanznachrichten.deTabula Rasa HealthCare, Inc.: Tabula Rasa HealthCare Reports First Quarter 2023 Financial ResultsMay 8, 2023 | markets.businessinsider.comTabula Rasa HealthCare Reports First Quarter 2023 Financial ResultsMay 7, 2023 | americanbankingnews.comTabula Rasa HealthCare (TRHC) to Release Earnings on MondayMay 5, 2023 | msn.comEarnings Preview: Tabula Rasa HealthCareApril 26, 2023 | finance.yahoo.comTabula Rasa HealthCare Schedules First Quarter 2023 Earnings Conference CallApril 24, 2023 | finance.yahoo.comNow permanent CEO, Brian Adams has Tabula Rasa focused on growth opportunities in wake of founder's exitApril 18, 2023 | finance.yahoo.comA Piece Of The Puzzle Missing From Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) Share PriceApril 17, 2023 | markets.businessinsider.comAnalysts Offer Insights on Technology Companies: Autodesk (ADSK) and Tabula Rasa HealthCare (TRHC)April 13, 2023 | finance.yahoo.comTabula Rasa HealthCare Provides Corporate UpdatesMarch 8, 2023 | markets.businessinsider.comAnalysts Offer Insights on Technology Companies: Keysight Technologies (KEYS), Tabula Rasa HealthCare (TRHC) and CrowdStrike Holdings (CRWD)March 8, 2023 | finance.yahoo.comTabula Rasa HealthCare, Inc. (NASDAQ:TRHC) Q4 2022 Earnings Call TranscriptMarch 8, 2023 | finance.yahoo.comOwning 42% shares,institutional owners seem interested in Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC),March 8, 2023 | finance.yahoo.comQ4 2022 Tabula Rasa HealthCare Inc Earnings CallMarch 7, 2023 | bizjournals.comTabula Rasa takes $57M loss on divestitures, completes sales of 3 non-core businessesMarch 6, 2023 | msn.comTabula Rasa HealthCare GAAP EPS of -$0.74 misses by $0.31, revenue of $82.71M beats by $1.9MSee More Headlines TRHC Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TRHC Company Calendar Last Earnings5/08/2023Today6/08/2023Next Earnings (Estimated)8/03/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Business services, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:TRHC CUSIPN/A CIK1651561 Webwww.tabularasahealthcare.com Phone(866) 648-2767FaxN/AEmployees1,027Year FoundedN/APrice Target and Rating Average Stock Price Forecast$6.63 High Stock Price Forecast$10.00 Low Stock Price Forecast$5.00 Forecasted Upside/Downside+5.2%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($5.54) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-147,510,000.00 Net Margins-42.17% Pretax Margin-19.88% Return on Equity-472.90% Return on Assets-10.74% Debt Debt-to-Equity RatioN/A Current Ratio1.66 Quick Ratio1.57 Sales & Book Value Annual Sales$320.68 million Price / Sales0.53 Cash FlowN/A Price / Cash FlowN/A Book Value($2.10) per share Price / Book-3.00Miscellaneous Outstanding Shares26,851,000Free Float18,715,000Market Cap$169.16 million OptionableOptionable Beta1.54 Key ExecutivesBrian W. AdamsPresident, Chief Executive Officer & DirectorMichael GreenhalghChief Operating OfficerThomas J. CancroChief Financial & Accounting OfficerJoseph J. FilippoliChief Information OfficerJacques TurgeonChief Scientific OfficerKey CompetitorsNutex HealthNASDAQ:NUTXInventivaNASDAQ:IVAAtara BiotherapeuticsNASDAQ:ATRACorvus PharmaceuticalsNASDAQ:CRVSLongboard PharmaceuticalsNASDAQ:LBPHView All CompetitorsInsiders & InstitutionsJPMorgan Chase & Co.Bought 208,664 shares on 5/18/2023Ownership: 1.180%Geode Capital Management LLCBought 12,909 shares on 5/16/2023Ownership: 0.924%Spears Abacus Advisors LLCSold 6,371 shares on 5/16/2023Ownership: 0.884%State Street CorpBought 4,100 shares on 5/16/2023Ownership: 0.346%Jane Street Group LLCBought 58,381 shares on 5/16/2023Ownership: 0.217%View All Insider TransactionsView All Institutional Transactions TRHC Stock - Frequently Asked Questions Should I buy or sell Tabula Rasa HealthCare stock right now? 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TRHC shares. View TRHC analyst ratings or view top-rated stocks. What is Tabula Rasa HealthCare's stock price forecast for 2023? 4 brokers have issued twelve-month price targets for Tabula Rasa HealthCare's shares. Their TRHC share price forecasts range from $5.00 to $10.00. On average, they anticipate the company's share price to reach $6.63 in the next year. This suggests a possible upside of 5.2% from the stock's current price. View analysts price targets for TRHC or view top-rated stocks among Wall Street analysts. How have TRHC shares performed in 2023? Tabula Rasa HealthCare's stock was trading at $4.95 at the beginning of 2023. Since then, TRHC stock has increased by 27.3% and is now trading at $6.30. View the best growth stocks for 2023 here. Are investors shorting Tabula Rasa HealthCare? Tabula Rasa HealthCare saw a drop in short interest in May. As of May 15th, there was short interest totaling 1,380,000 shares, a drop of 13.8% from the April 30th total of 1,600,000 shares. Based on an average trading volume of 116,800 shares, the days-to-cover ratio is presently 11.8 days. Currently, 5.8% of the shares of the stock are sold short. View Tabula Rasa HealthCare's Short Interest. When is Tabula Rasa HealthCare's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023. View our TRHC earnings forecast. How were Tabula Rasa HealthCare's earnings last quarter? Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) issued its quarterly earnings results on Monday, May, 8th. The company reported ($0.12) earnings per share for the quarter, beating the consensus estimate of ($0.31) by $0.19. The company earned $88.28 million during the quarter, compared to analysts' expectations of $83.86 million. Tabula Rasa HealthCare had a negative trailing twelve-month return on equity of 472.90% and a negative net margin of 42.17%. What guidance has Tabula Rasa HealthCare issued on next quarter's earnings? Tabula Rasa HealthCare issued an update on its second quarter 2023 earnings guidance on Monday, May, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $88.00 million-$90.00 million, compared to the consensus revenue estimate of $85.94 million. What is Calvin H. Knowlton, BScPharm, MDiv, PhD's approval rating as Tabula Rasa HealthCare's CEO? 24 employees have rated Tabula Rasa HealthCare Chief Executive Officer Calvin H. Knowlton, BScPharm, MDiv, PhD on Glassdoor.com. Calvin H. Knowlton, BScPharm, MDiv, PhD has an approval rating of 91% among the company's employees. This puts Calvin H. Knowlton, BScPharm, MDiv, PhD in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Tabula Rasa HealthCare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), QUALCOMM (QCOM), Adobe (ADBE), Micron Technology (MU), Boeing (BA), Salesforce (CRM), Intel (INTC) and Netflix (NFLX). When did Tabula Rasa HealthCare IPO? (TRHC) raised $60 million in an initial public offering (IPO) on Thursday, September 29th 2016. The company issued 4,300,000 shares at $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray acted as the underwriters for the IPO and Baird and Stifel were co-managers. What is Tabula Rasa HealthCare's stock symbol? Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC." Who are Tabula Rasa HealthCare's major shareholders? Tabula Rasa HealthCare's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include UBS Group AG (4.84%), Wasatch Advisors LP (3.27%), JPMorgan Chase & Co. (1.18%), Acadian Asset Management LLC (1.15%), Geode Capital Management LLC (0.92%) and Spears Abacus Advisors LLC (0.88%). Insiders that own company stock include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Indaba Capital Management, LP, Jan Berger, Michael Greenhalgh, Michael J Purcell, Orsula V Knowlton, Orsula V Knowlton, Samira Beckwith and Thomas Cancro. View institutional ownership trends. How do I buy shares of Tabula Rasa HealthCare? Shares of TRHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Tabula Rasa HealthCare's stock price today? One share of TRHC stock can currently be purchased for approximately $6.30. How much money does Tabula Rasa HealthCare make? Tabula Rasa HealthCare (NASDAQ:TRHC) has a market capitalization of $169.16 million and generates $320.68 million in revenue each year. The company earns $-147,510,000.00 in net income (profit) each year or ($5.54) on an earnings per share basis. How many employees does Tabula Rasa HealthCare have? The company employs 1,027 workers across the globe. How can I contact Tabula Rasa HealthCare? Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The official website for the company is www.tabularasahealthcare.com. The company can be reached via phone at (866) 648-2767 or via email at tabularasa@westwicke.com. This page (NASDAQ:TRHC) was last updated on 6/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tabula Rasa HealthCare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.